ACHC Valuation

Acadia Healthcare Company Inc

Add to Watchlist

Advanced Chart

21.740

-1.23(-5.355%)1D

Overview
Forecast
Valuation
Earnings

ACHC Relative Valuation

ACHC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ACHC is overvalued; if below, it's undervalued.

Historical Valuation

Acadia Healthcare Company Inc (ACHC) is now in the Undervalued zone, suggesting that its current forward PE ratio of 8.51 is considered Undervalued compared with the five-year average of 19.58. The fair price of Acadia Healthcare Company Inc (ACHC) is between 49.17 to 68.24 according to relative valuation methord. Compared to the current price of 21.74 USD , Acadia Healthcare Company Inc is Undervalued By 55.79%.

Relative Value

Fair Zone

49.17-68.24

Current Price：21.74

55.79%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.68

P/B

Median3y

2.09

Median5y

2.09

-12.81

FCF Yield

Median3y

-4.29

Median5y

0.09

Competitors Valuation Multiple

The average P/S ratio for ACHC's competitors is 2.18, providing a benchmark for relative valuation. Acadia Healthcare Company Inc Corp (ACHC) exhibits a P/S ratio of 0.60, which is -72.63% above the industry average. Given its robust revenue growth of 0.32%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

ACHC.O

Acadia Healthcare Company Inc

0.60

Average P/S: 2.18

0.32%